Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Newegg Stock Was Down This Week
Demitri Kalogeropoulos
|
Sep 9, 2022
Sales trends are looking weak heading into the core holiday shopping period.
BeyondSpring, Inc. (BYSI) Q4 2021 Earnings Call Transcript
Motley Fool Transcribing
|
Apr 14, 2022
BYSI earnings call for the period ending March 31, 2022.
Newegg Commerce Shares Rose 36% This Week -- Here's How
Anders Bylund
|
Nov 12, 2021
The computer-hardware e-commerce veteran has drawn attention from meme stock traders.
Here's Why Newegg Shares Crashed in September
Anders Bylund
|
Oct 7, 2021
Investors don't quite know what to make of this online retailer despite two full decades of operating history.
September Sell-Off: Buy These Stocks While They're Down
Anders Bylund
|
Sep 22, 2021
Successful investors buy great stocks when everyone else is selling in a panic. These high-quality stocks are trading at a market-risk discount right now and you should take advantage of these generous buying windows.
BeyondSpring inc (BYSI) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
|
Sep 10, 2021
BYSI earnings call for the period ending June 30, 2021.
How Newegg Commerce Shares Gained 13% Last Month
Anders Bylund
|
Sep 3, 2021
The electronics retailer's market moves in August had little to do with serious business news.
Why BeyondSpring Stock Is Soaring This Week
Cory Renauer
|
Aug 27, 2021
A lucrative partnership deal with a pharmaceutical giant in China bodes well for BeyondSpring's potential new blockbuster cancer drug.
This Biotech Stock Just Skyrocketed by 170%. Is It a Buy?
Prosper Junior Bakiny
|
Aug 10, 2021
Don't be too quick to pull the trigger.
Why BeyondSpring Stock Skyrocketed Today
Joe Tenebruso
|
Aug 4, 2021
The biotech's experimental cancer therapy could be a game-changer.
View More Articles